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Background & objectives: Association of hepatitis G virus (HGV) with acute viral hepatitis (AVH) and
fulminant hepatitis (FH) is not clearly understood.This study was designed to asses the occurrence of
HGV infection and its relationship with other hepatotropic viruses in patients with FH and AVH and also
to determine the nucleotide sequence of  HGV isolates.
Methods: The study included 100 patients of FH and 125 of AVH on the basis of clinical examination,
liver function test and serology for hepatitis A, B, C and E virus. HGV RNA was detected by reverse
transcriptase-polymerase chain reaction (RT-PCR) and direct sequencing for 4 randomly selected samples
followed by phylogenetic analysis.
Results: Of the 100 patients with FH, 30 were negative for hepatitis viruses A, B, C and E by serology
(non A - non E) while 60 were negative in the AVH group. In the non A- non -E hepatitis group, HGV was
positive in 16.66 per cent (5/30) cases of FH, 10 per cent (6/60) cases of AVH and 6 per cent (6/100) of
healthy controls. The difference in HGV seropositivity between FH and AVH patients was statistically
not significant compared to healthy controls, while HBV and HCV infections were significant. The four
isolates sequenced seemed to be of same type and close to Chinese strain of HGV (Y13755.1 Y13756.1
Y15407, and U67782) on phylogeny.
Interpretation & conclusion: In HGV infection was not found to be clinically significant as well as non-
pathogenic in the patients of FH and AVH and appeared to be an innocent bystander in the course of the
disease. The four sequenced HGV isolates showed close pairing with Chinese strains.
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Hepatitis G virus (HGV) infection is thought to be
a blood borne virus. However, little is known about the
epidemiology, transmission, replication site, and disease
inducing capacity of this virus. Association of HGV with
fulminant hepatitis (FH) and acute viral hepatitis (AVH)
is still controversial and its clinical significance is to be
clearly understood. HGV infection has been reported in
the patients with AVH, chronic hepatitis, fulminant
hepatitis, haemodialysis, intravenous drug abuser and
blood donors around the world1.
HGV is a positive sense single stranded RNA
genome, approximately 9.4 Kilo base and belongs to
Flaviviridae family. Though HGV genome is related to
anti HCV. The HGV assay was done by reverse
transcriptase polymerase chain reaction (RT-PCR). Total
RNA was extracted from 100 µl serum by acid-
guanidinium-phenol-chloroform as descried earlier8-10.
The HBV DNA, HCV RNA and HGV RNA were
amplified using PCR and RT-PCR respectively as
described elsewhere8,10,11. The sequencing of the positive
HGV PCR product (cDNA) was done from the
Macrogen Inc, Korea on commercial basis. The
sequences were aligned using Neighbour joining method
of Clustal W software (1.82) multiple alignments of the
European Bioinformatics Institute, UK for phylogeny12.
Results & Discussion
HGV infection was seen in 16 per cent (16/100)
cases of FH, 10.4 per cent  (13/125) of AVH and
6 per cent (6/100) of controls. The difference in the
occurrence of HGV was not statistically significant is
the patients of AVH and FH compared to controls.
However, the seroprevalence of HBV and HCV was
found to be significantly higher (P<0.05) in patients as
compared to healthy controls (Data not shown). In the
non A-non E cases of FH and AVH, the HGV positivity
was seen in 16.66 (5/30) and 10 per cent (6/60) of the
cases, respectively.
Clinical significance of hepatitis G virus in the
patients of AVH and FH studied in different countries
showed conflicting reports. In our earlier studies, we
have reported the HGV infection in 14.3 per cent cases
of AVH, 11.4 per cent cases of FH, 4 per cent in general
population, 46.6 per cent in commercial blood donors
and 6 per cent cases of chronic renal failure on
haemodialysis8-11,13. Varying HGV seropositivity has
been shown in different studies from India. Panda et
al14 reported 8.3 per cent HGV infection while
Arankelle  et al15 showed 3.58 per cent patients with
FH positive for HGV infection. Dawson et al16 reported
42.7 per cent seroprevalence of HGV in non A non E
hepatitis patients with FH which was comparable to a
study from Japan16. Heringlake et al17 et al from
Germany reported 50 per cent of FH patients positive
for HGV. HBV DNA was not detected in any of the
serologically negative cases. However, HCV, RNA was
detected in one serologically negative case. Hepatitis
E virus infection was observed in 49 per cent  (49/
100) cases of FH and 35.2 per cent  (44/125) cases of
AVH. Hepatitis A virus infection was seen in 9 per
cent (9/100) cases of FH and 10.4 per cent (13/125)
cases of and AVH. This shows the predominant HEV
virus infection in the cases of AVH and FH. The co-
infections of HGV observed with hepatitis A, B and E
hepatitis C virus (HCV), it is too divergent to be
classified as the genotype of HCV2. It is well established
that HCV exhibits significant genetic heterogeneity not
only between different patients but also in the same
individual and the same is expected in HGV3. Sequence
variation in HGV ranges from 0.5 to 20.7 per cent  at
the nucleotide level, and from 0 to 16.5 per cent at the
amino acid level4. HGV has considerable degree of
genetic heterogeneity, the  NS3 region of HGV has
sequence divergence of 10-20 per cent.
Reports from Argentina and Italy showed 30.6 and
39 per cent seroprevalence of HGV respectively in
fulminant hepatitis patients5,6. A study from Japan
reported HGV in 50 per cent of non A non E hepatitis
patients with FH; the higher prevalence may be because
of small sample7.
In view of paucity of information about HGV
infection in the patients with FH and AVH from northern
India, this study was designed to assess the occurrence
and clinical relevance of hepatitis G virus isolates in
patients with acute viral hepatitis and fulminant hepatitis
and to compare their nucleotide sequences with other
HGV isolates of gene bank.
Material & Methods
A total of 100 consecutive patients (mean age: 29.57
±15.33 yr) of FH and 125 patients (mean age:
27.86±9.73 yr) of AVH attending the Medical OPD and
wards of Lok Nayak Hospital, New Delhi, India during
the period October 2002 to July 2004 were included in
the study. The control group included 100 apparently
healthy individuals (male:female 78:22; mean age
31.24±7.41 yr) from the blood bank. 5 ml of blood was
collected and separated serum samples were stored at
-20°C deep freezer till analysis. The patients were
included on the basis of predesigned proforma with
relevant information with respect to case history, risk
factors, clinical examination, liver function test and
serological tests for HBsAg, IgM HBc, HBeAg, IgM
HAV, IgM HEV and anti HCV. The written informed
consent was obtained from all the patients and the study
was approved by the ethical committee of the institution.
Serum samples were screened for HBsAg using 3rd
generation ELISA kit (Biokit; S.A., Spain), IgM HBc
and HBeAg using ELISA kit of RADIM SpA Italy, IgM
HAV and IgM HEV using ELISA kit of Medical
Biological Services S.R.L. Italy, and anti HCV antibody
was tested by 3rd generation ELISA kit (General
Biological Corporation, Taiwan). The serum samples
of healthy controls were only screened for HBsAg and
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in the patients of AVH and FH may be because of
common mode of transmission.
Liver function profile of HGV positive and negative
cases was comparable. The aminotransferase level that
believed to be correlated with the disease activity, was
found to be comparable in HGV positive and negative
cases of AVH and FH (data not shown). The liver
function profile of patients with only HGV and those
co-infected with HEV was also comparable. Studies
from US, Japan, Brazil, and China have not indicated
any clinical significance of HGV infection in the patients
of fulminant hepatitis6,18,19. Our results also supported
the same. Patients with only HGV infection had normal
liver function profile and also clinically asymptomatic
on six month follow up. No mortality was observed in
the patients of AVH including HGV positive cases.
However, of the 16 HGV positive patients of fulminant
hepatitis, 8 died.  Of the 5 HGV infected non A non E
cases of FH, 2 expired. These results suggest that HGV
may not have any pathogenic role in the course of acute
viral hepatitis and fulminant hepatitis.
The four selected HGV isolates, two each from FH
and AVH were sequenced. On analysis of 101-nucleotide
sequence of NS3/ helicase region, all the four HGV
isolates nucleotide sequence showed pairing to each
other when subjected to clustal W (1.82) multiple
alignments with other sequences of NS3/helicase region
available in the genbank (NCBI). Inference could not
be drawn regarding genotype because the very small
fragment (~100 bp) was sequenced. The NS3/helicase
region is not considered to be ideal for genotyping of
the hepatitis G virus19,20.  Studies on NS3 region of HGV
have been reported from the Spain, Germany, China,
USA and UK21-24. The variation amongst HGV isolates
across several continents was between 10-30 per cent
while the variation of HCV isolates between geographic
regions is greater than 30 per cent across the whole
genome21. This may be due to weak selection pressure
of the HGV Indian isolates Ind 1 HGV-DQ076328, Ind
2 HGV- DQ076329 of FH and Ind 3HGV-DQ076330,
Ind 3 HGV-DQ076331 of AVH patients. All four Indian
isolates showed close pairing to each other on phylogeny
suggestive of the same type (Fig.). These HGV Indian
isolates showed pairing with the Chinese (U67782,
Y15407, Y13755.1, Y13756.1) isolates in phylogeny
compared with the sequences of Spain, Germany, USA
and UK (NCBI Server). The isolates of China U67782
and Y15407 are of prototype showing pairing with the
Indian isolates.
Fig. Phylogenetic tree of four Indian HGV sequences with the other sequences of China, Spain, Germany, USA, and UK (prepared by the
Clustal multiple alignment software of European Bioinformatics Institute, UK.
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In conclusion, the HGV and its co-infection with
other hepatotrophic viruses do not seem to have a
pathogenic role, and the clinicians need not to look for
the presence of HGV infection in non A-E cases of FH
and AVH. The HGV infection appears to be clinically
silent and innocent bystander in the course of FH and
AVH. HEV continues to be major viral infection in these
patients. The geographical basis of phylogeny predicts
that the Indian isolates may be of prototype and close to
Chinese strain.
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